Thymosin Alpha-1 (TA1)

Immune Approved (Asia, Latin America)

Natural peptide produced by the thymus that modulates immune function. Approved in multiple countries for hepatitis and as cancer adjuvant.

Key Data

Research Status
Approved (Asia, Latin America)
Half-Life
2 hours
Administration
Subcutaneous injection
Typical Dosage
1.6 mg twice weekly

Mechanism of Action

Enhances T-cell function, dendritic cell maturation, and overall immune surveillance.

Reported Benefits

All information is presented for Research Use Only (RUO). Not medical advice.

← All Peptides Dosing Calculator Community Forum Home